Clinical Trial Update: A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.) [Phase 3]

View source ↗

Summary

Completed Phase 3 clinical trial evaluating open-label pramipexole with titration in idiopathic restless legs syndrome patients who initially responded to six m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED